OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Bile Duct Stone reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,115 reports · 71 co-occurring drugs

As of the last recalculation, Bile Duct Stone appears in 3,115 FAERS reports alongside 71 co-occurring drug terms. The strongest observed disproportionality signal is DROSPIRENONE AND ETHINYL ESTRADIOL (PRR 44.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Drospirenone And Ethinyl Estradiol26944.444.7
Ursodiol6119.119.1
Ursosiol5218.218.2
Teduglutide2914.514.5
Febuxostat Tablets 40 Mg2013.213.2
Febuxostat Tablets 80 Mg2013.213.2
Octreotide Acetate5812.912.9
Lanreotide Acetate1512.812.9
Dicyclomine Hydrochloride209.49.4
Ciclesonide199.49.4
Pitavastatin Calcium149.29.2
Febuxostat228.88.8
Promethazine Hydrochloride217.67.6
Telmisartan197.27.2
Pancrelipase396.86.8
Cefazolin96.66.6
Meperidine Hydrochloride96.56.5
Ceftriaxone Sodium376.56.5
Dalteparin Sodium106.36.3
Atazanavir136.16.1
Hyoscyamine Sulfate85.85.8
Rabeprazole195.85.8
Cefazolin Sodium105.65.6
Cholestyramine105.55.5
Amlodipine Besylate And Valsartan95.45.4
Timolol Maleate85.45.4
Ceftriaxone255.15.1
Liraglutide375.15.1
Olmesartan Medoxomil264.94.9
Methoxy Polyethylene Glycol-Epoetin Beta84.94.9
Piperacillin Sodium And Tazobactam Sodium144.84.8
Rabeprazole Sodium194.74.7
Primidone74.64.6
Oral Semaglutide494.54.5
Baricitinib64.24.2
Sitagliptin444.14.1
Linagliptin114.04.0
Sitagliptin And Metformin Hydrochloride134.04.0
Ritonavir 100 Mg94.04.0
Vedolizumab483.83.8
Prochlorperazine Maleate53.63.6
Ravulizumab73.53.5
Eculizumab273.33.3
Levodopa63.33.3
Dutasteride43.33.3
Naltrexone Hydrochloride And Bupropion Hydrochloride43.13.1
Calcium, Magnesium, Potassium, And Sodium Oxybates43.13.1
Tenofovir Disoproxil Fumarate Tablets43.13.1
Lenvatinib153.13.1
Regorafenib52.92.9
Rifaximin92.92.9
Atezolizumab162.82.8
Darbepoetin Alfa222.72.7
Irinotecan Hydrochloride52.62.6
Inclisiran32.52.5
Trifluridine And Tipiracil42.52.5
Dornase Alfa72.42.4
Sofosbuvir72.42.4
Durvalumab72.32.3
Nivolumab322.22.2
Exenatide172.22.2
Emicizumab42.22.2
Elexacaftor, Tezacaftor, And Ivacaftor42.12.1
Ustekinumab322.12.1
Tirzepatide482.02.0
Romosozumab-Aqqg42.02.0
Ledipasvir And Sofosbuvir51.71.7
Dulaglutide211.61.6
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride71.51.5
Patiromer31.41.4
Pimavanserin Tartrate60.70.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.